Literature DB >> 30955516

Community-acquired Pneumonia and Hospital-acquired Pneumonia.

Charles W Lanks1, Ali I Musani2, David W Hsia3.   

Abstract

Pneumonia is among the leading causes of morbidity and mortality worldwide. Although Streptococcus pneumoniae is the most likely cause in most cases, the variety of potential pathogens can make choosing a management strategy a complex endeavor. The setting in which pneumonia is acquired heavily influences diagnostic and therapeutic choices. Because the causative organism is typically unknown early on, timely administration of empiric antibiotics is a cornerstone of pneumonia management. Disease severity and rates of antibiotic resistance should be carefully considered when choosing an empiric regimen. When complications arise, further work-up and consultation with a pulmonary specialist may be necessary.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAP; Community-acquired pneumonia; HAP; Hospital-acquired pneumonia; Pneumonia

Mesh:

Substances:

Year:  2019        PMID: 30955516     DOI: 10.1016/j.mcna.2018.12.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  41 in total

1.  Risk factors and pathogenic microorganism characteristics for pneumonia in convalescent patients with stroke: A retrospective study of 380 patients from a rehabilitation hospital: A retrospective study of risk factors and pathogenic microorganism characteristics for pneumonia in convalescent patients with stroke.

Authors:  Jia Xu; Zhiling Yang
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-14       Impact factor: 2.136

2.  Multimodality molecular imaging of the alveolar-capillary barrier in lung disease using albumin based optical and PET tracers.

Authors:  Andrei Molotkov; Nikunj Bhatt; Mikhail Doubrovin; John Castrillon; Christopher Massa; Adam Gerber; Jeanine D'Armiento; Monica Goldklang; Akiva Mintz
Journal:  Mol Biomed       Date:  2020-12-20

Review 3.  Pyroptosis-Induced Inflammation and Tissue Damage.

Authors:  Yinan Wei; Ling Yang; Ankit Pandeya; Jian Cui; Yan Zhang; Zhenyu Li
Journal:  J Mol Biol       Date:  2021-10-13       Impact factor: 5.469

Review 4.  Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.

Authors:  Chrysi Keskinidou; Alice G Vassiliou; Ioanna Dimopoulou; Anastasia Kotanidou; Stylianos E Orfanos
Journal:  J Inflamm Res       Date:  2022-06-15

5.  Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.

Authors:  Tian Qin; Yajie Wang; Jianping Deng; BaoHong Xu; Xiong Zhu; Jitao Wang; Haijian Zhou; Na Zhao; Fangfang Jin; Hongyu Ren; Huizhu Wang; Qun Li; Xinmin Xu; Yumei Guo; Ruihong Li; Yanwen Xiong; XiaoXia Wang; Jiane Guo; Han Zheng; Xuexin Hou; Kanglin Wan; Jianzhong Zhang; Jinxing Lu; Biao Kan; Jianguo Xu
Journal:  Microbiol Spectr       Date:  2022-05-17

Review 6.  Lefamulin: a New Hope in the Field of Community-Acquired Bacterial Pneumonia.

Authors:  Shubham Adhikary; Meher Kaur Duggal; Saraswathy Nagendran; Meena Chintamaneni; Hardeep Singh Tuli; Ginpreet Kaur
Journal:  Curr Pharmacol Rep       Date:  2022-07-06

7.  Clinical Features and Risk Factors of Severe Pneumonia in Children With Acute Lymphoblastic Leukemia.

Authors:  Chun-Yan Liu; Cheng Li
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.569

8.  Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.

Authors:  Abla Tannous; Susan L Levinson; James Bolognese; Steven M Opal; Mark J DiNubile
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

9.  The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis.

Authors:  Catherine Steffens; Minhee Sung; Lori A Bastian; E Jennifer Edelman; Alexandria Brackett; Craig G Gunderson
Journal:  J Gen Intern Med       Date:  2020-09-03       Impact factor: 5.128

10.  Pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose intravenous ceftobiprole in healthy Chinese participants.

Authors:  Wan-Zhen Li; Hai-Lan Wu; Yuan-Cheng Chen; Bei-Ning Guo; Xiao-Fen Liu; Yu Wang; Ju-Fang Wu; Jing Zhang
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.